Literature DB >> 23283964

The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope.

Maino Tahara1, Shinji Ohno, Kouji Sakai, Yuri Ito, Hideo Fukuhara, Katsuhiro Komase, Melinda A Brindley, Paul A Rota, Richard K Plemper, Katsumi Maenaka, Makoto Takeda.   

Abstract

Here, we provide direct evidence that the receptor-binding site of measles virus (MV) hemagglutinin protein itself forms an effective conserved neutralizing epitope (CNE). Several receptor-interacting residues constitute the CNE. Thus, viral escape from neutralization has to be associated with loss of receptor-binding activity. Since interactions with both the signaling lymphocyte activation molecule (SLAM) and nectin4 are critical for MV pathogenesis, its escape, which results from loss of receptor-binding activity, should not occur in nature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23283964      PMCID: PMC3592127          DOI: 10.1128/JVI.03029-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.

Authors:  Sompong Vongpunsawad; Numan Oezgun; Werner Braun; Roberto Cattaneo
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

2.  Characterization of major structural proteins of measles virus with monoclonal antibodies.

Authors:  T A Sato; A Fukuda; A Sugiura
Journal:  J Gen Virol       Date:  1985-07       Impact factor: 3.891

3.  Epithelial-mesenchymal transition abolishes the susceptibility of polarized epithelial cell lines to measles virus.

Authors:  Yuta Shirogane; Makoto Takeda; Maino Tahara; Satoshi Ikegame; Takanori Nakamura; Yusuke Yanagi
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

Review 4.  Measles: not just another viral exanthem.

Authors:  Trevor Duke; Charles S Mgone
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

5.  Risk analysis for measles reintroduction after global certification of eradication.

Authors:  Raymond Sanders; Alya Dabbagh; David Featherstone
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

6.  Molecular characterization of epitopes on the measles virus hemagglutinin protein.

Authors:  A Hu; H Sheshberadaran; E Norrby; J Kövamees
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

7.  Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM.

Authors:  Seiichi Kato; Shinji Ohgimoto; Luna Bhatta Sharma; Sekiko Kurazono; Minoru Ayata; Katsuhiro Komase; Makoto Takeda; Kaoru Takeuchi; Toshiaki Ihara; Hisashi Ogura
Journal:  Vaccine       Date:  2009-04-23       Impact factor: 3.641

8.  Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4.

Authors:  Xiaoai Zhang; Guangwen Lu; Jianxun Qi; Yan Li; Yan He; Xiang Xu; Jia Shi; Catherine W-H Zhang; Jinghua Yan; George F Gao
Journal:  Nat Struct Mol Biol       Date:  2012-12-02       Impact factor: 15.369

9.  Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response.

Authors:  O T Ertl; D C Wenz; F B Bouche; G A M Berbers; C P Muller
Journal:  Arch Virol       Date:  2003-11       Impact factor: 2.574

10.  Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.

Authors:  Ryan S Noyce; Daniel G Bondre; Michael N Ha; Liang-Tzung Lin; Gary Sisson; Ming-Sound Tsao; Christopher D Richardson
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

View more
  16 in total

1.  Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein.

Authors:  Yuma Sato; Shumpei Watanabe; Yoshinari Fukuda; Takao Hashiguchi; Yusuke Yanagi; Shinji Ohno
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

2.  Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial].

Authors:  Ikechukwu Adigweme; Edem Akpalu; Mohammed Yisa; Simon Donkor; Lamin B Jarju; Baba Danso; Anthony Mendy; David Jeffries; Abdoulie Njie; Andrew Bruce; Michael Royals; James L Goodson; Mark R Prausnitz; Devin McAllister; Paul A Rota; Sebastien Henry; Ed Clarke
Journal:  Trials       Date:  2022-09-14       Impact factor: 2.728

3.  Antibody neutralization of retargeted measles viruses.

Authors:  Patrycja J Lech; Roland Pappoe; Takafumi Nakamura; Gregory J Tobin; Peter L Nara; Stephen J Russell
Journal:  Virology       Date:  2014-03-14       Impact factor: 3.616

4.  Molecular evolution of haemagglutinin (H) gene in measles virus.

Authors:  Hirokazu Kimura; Mika Saitoh; Miho Kobayashi; Haruyuki Ishii; Takeshi Saraya; Daisuke Kurai; Hiroyuki Tsukagoshi; Komei Shirabe; Atsuyoshi Nishina; Kunihisa Kozawa; Makoto Kuroda; Fumihiko Takeuchi; Tsuyoshi Sekizuka; Hisanori Minakami; Akihide Ryo; Makoto Takeda
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

5.  Genetic characterization of the hemagglutinin genes of wild-type measles virus circulating in china, 1993-2009.

Authors:  Songtao Xu; Yan Zhang; Zhen Zhu; Chunyu Liu; Naiying Mao; Yixin Ji; Huiling Wang; Xiaohong Jiang; Chongshan Li; Wei Tang; Daxing Feng; Changyin Wang; Lei Zheng; Yue Lei; Hua Ling; Chunfang Zhao; Yan Ma; Jilan He; Yan Wang; Ping Li; Ronghui Guan; Shujie Zhou; Jianhui Zhou; Shuang Wang; Hong Zhang; Huanying Zheng; Leng Liu; Hemuti Ma; Jing Guan; Peishan Lu; Yan Feng; Yanjun Zhang; Shunde Zhou; Ying Xiong; Zhuoma Ba; Hui Chen; Xiuhui Yang; Fang Bo; Yujie Ma; Yong Liang; Yake Lei; Suyi Gu; Wei Liu; Meng Chen; David Featherstone; Youngmee Jee; William J Bellini; Paul A Rota; Wenbo Xu
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 6.  Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.

Authors:  Maino Tahara; Jean-Philippe Bürckert; Kazuhiko Kanou; Katsumi Maenaka; Claude P Muller; Makoto Takeda
Journal:  Viruses       Date:  2016-08-02       Impact factor: 5.048

Review 7.  Eradication of measles: remaining challenges.

Authors:  Heidemarie Holzmann; Hartmut Hengel; Matthias Tenbusch; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2016-03-02       Impact factor: 3.402

8.  Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies.

Authors:  Nicola Logan; Elizabeth McMonagle; Angharad A Drew; Emi Takahashi; Michael McDonald; Michael D Baron; Martin Gilbert; Sarah Cleaveland; Daniel T Haydon; Margaret J Hosie; Brian J Willett
Journal:  Vaccine       Date:  2015-12-17       Impact factor: 3.641

Review 9.  Constraints on the Genetic and Antigenic Variability of Measles Virus.

Authors:  Shannon M Beaty; Benhur Lee
Journal:  Viruses       Date:  2016-04-21       Impact factor: 5.048

10.  Enhanced immunosurveillance for animal morbilliviruses using vesicular stomatitis virus (VSV) pseudotypes.

Authors:  Nicola Logan; William G Dundon; Adama Diallo; Michael D Baron; M James Nyarobi; Sarah Cleaveland; Julius Keyyu; Robert Fyumagwa; Margaret J Hosie; Brian J Willett
Journal:  Vaccine       Date:  2016-10-11       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.